Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Panzuto

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Journal of Clinical Medicine|January 15, 2021
Clinical Challenges in the Management of Neuroendocrine TumorsFrancesco Panzuto
Recenti Progressi in Medicina|December 19, 2003
[Chemotherapy and NSAIDs in neoplastic disease. Role of anti-secretory preventive therapy]Bruno Annibale, Francesco Panzuto
Cancer Treatment Reviews|July 19, 2024
Comparative analysis of international guidelines on the management of advanced non-functioning well-differentiated pancreatic neuroendocrine tumorsFrancesco Panzuto, Angela Lamarca, Nicola Fazio
Expert Opinion on Drug Safety|February 3, 2021
Exocrine pancreatic insufficiency and somatostatin analogs in patients with neuroendocrine neoplasiaFrancesco Panzuto, Ludovica Magi, Maria Rinzivillo
Expert Opinion on Drug Safety|April 8, 2021
Reply to Dr. Hall and coworkersFrancesco Panzuto, Ludovica Magi, Maria Rinzivillo
The Lancet Regional Health. Europe|July 18, 2025
Peptide receptor radionuclide therapy in G3 gastroenteropancreatic neuroendocrine tumors: a missed opportunity for European patients?Francesco Panzuto, Mauro Cives, Jonathan Strosberg
World Journal of Gastroenterology|February 10, 2025
Rectal neuroendocrine tumors: Can we predict their behavior?Elisabetta Dell'Unto, Francesco Panzuto, Gianluca Esposito
The American Journal of Gastroenterology|May 27, 2025
Letter to the EditorElisabetta Dell'Unto, Francesco Panzuto, Bruno Annibale
Oncotarget|April 14, 2017
Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors: a systematic review and meta-analysisElettra Merola, Francesco Panzuto, Gianfranco Delle Fave
Cancer Treatment Reviews|November 1, 2025
Corrigendum to "The importance of education and training in neuroendocrine neoplasms: challenges and opportunities for multidisciplinary management". [Cancer Treat. Rev. 139 (2025) 102998]Francesco Panzuto, Simona Barbi, Annalisa Trama, et al.
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Journal of Clinical Medicine|January 15, 2021
Clinical Challenges in the Management of Neuroendocrine TumorsFrancesco Panzuto
Recenti Progressi in Medicina|December 19, 2003
[Chemotherapy and NSAIDs in neoplastic disease. Role of anti-secretory preventive therapy]Bruno Annibale, Francesco Panzuto
Cancer Treatment Reviews|July 19, 2024
Comparative analysis of international guidelines on the management of advanced non-functioning well-differentiated pancreatic neuroendocrine tumorsFrancesco Panzuto, Angela Lamarca, Nicola Fazio
Expert Opinion on Drug Safety|February 3, 2021
Exocrine pancreatic insufficiency and somatostatin analogs in patients with neuroendocrine neoplasiaFrancesco Panzuto, Ludovica Magi, Maria Rinzivillo
Expert Opinion on Drug Safety|April 8, 2021
Reply to Dr. Hall and coworkersFrancesco Panzuto, Ludovica Magi, Maria Rinzivillo
The Lancet Regional Health. Europe|July 18, 2025
Peptide receptor radionuclide therapy in G3 gastroenteropancreatic neuroendocrine tumors: a missed opportunity for European patients?Francesco Panzuto, Mauro Cives, Jonathan Strosberg
World Journal of Gastroenterology|February 10, 2025
Rectal neuroendocrine tumors: Can we predict their behavior?Elisabetta Dell'Unto, Francesco Panzuto, Gianluca Esposito
The American Journal of Gastroenterology|May 27, 2025
Letter to the EditorElisabetta Dell'Unto, Francesco Panzuto, Bruno Annibale
Oncotarget|April 14, 2017
Antiproliferative effect of somatostatin analogs in advanced gastro-entero-pancreatic neuroendocrine tumors: a systematic review and meta-analysisElettra Merola, Francesco Panzuto, Gianfranco Delle Fave
Cancer Treatment Reviews|November 1, 2025
Corrigendum to "The importance of education and training in neuroendocrine neoplasms: challenges and opportunities for multidisciplinary management". [Cancer Treat. Rev. 139 (2025) 102998]Francesco Panzuto, Simona Barbi, Annalisa Trama, et al.
Pageof 16